- Home
- CDTX vs NXRT Comparison
CDTX vs NXRT Comparison
Compare CDTX & NXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- NXRT
- Stock Information
- Founded
- CDTX 2012
- NXRT 2014
- Country
- CDTX United States
- NXRT United States
- Employees
- CDTX N/A
- NXRT N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- NXRT Real Estate Investment Trusts
- Sector
- CDTX Health Care
- NXRT Real Estate
- Exchange
- CDTX Nasdaq
- NXRT Nasdaq
- Market Cap
- CDTX 980.1M
- NXRT 859.4M
- IPO Year
- CDTX 2015
- NXRT N/A
- Fundamental
- Price
- CDTX $63.31
- NXRT $31.19
- Analyst Decision
- CDTX Strong Buy
- NXRT Hold
- Analyst Count
- CDTX 11
- NXRT 6
- Target Price
- CDTX $52.11
- NXRT $41.88
- AVG Volume (30 Days)
- CDTX 659.9K
- NXRT 158.5K
- Earning Date
- CDTX 08-07-2025
- NXRT 07-29-2025
- Dividend Yield
- CDTX N/A
- NXRT 6.50%
- EPS Growth
- CDTX N/A
- NXRT N/A
- EPS
- CDTX N/A
- NXRT N/A
- Revenue
- CDTX $302,000.00
- NXRT $254,446,000.00
- Revenue This Year
- CDTX N/A
- NXRT N/A
- Revenue Next Year
- CDTX N/A
- NXRT $5.28
- P/E Ratio
- CDTX N/A
- NXRT N/A
- Revenue Growth
- CDTX N/A
- NXRT N/A
- 52 Week Low
- CDTX $10.14
- NXRT $30.98
- 52 Week High
- CDTX $66.95
- NXRT $48.37
- Technical
- Relative Strength Index (RSI)
- CDTX 70.66
- NXRT 29.87
- Support Level
- CDTX $60.71
- NXRT $32.58
- Resistance Level
- CDTX $66.95
- NXRT $34.16
- Average True Range (ATR)
- CDTX 4.25
- NXRT 0.83
- MACD
- CDTX -0.39
- NXRT -0.22
- Stochastic Oscillator
- CDTX 79.25
- NXRT 1.27
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About NXRT NexPoint Residential Trust Inc.
NexPoint Residential Trust Inc is a real estate investment trust company. Its objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. The company seeks to achieve these objectives through targeted management and a capex value-add program. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.